CNS embryonal tumors, a formidable challenge in pediatric oncology, arise from embryonic cells within the central nervous system. Delving into their molecular underpinnings, researchers uncover intricate genetic anomalies and aberrant signaling pathways fueling their aggressive growth. With cutting-edge imaging and molecular profiling techniques, clinicians refine diagnostic precision and tailor therapeutic strategies.
Recent strides spotlight immunotherapy and targeted interventions, presenting potential breakthroughs in preclinical and clinical realms. By deciphering the intricate molecular landscapes of these tumors, the research community endeavors to forge novel treatment modalities, striving to ameliorate outcomes and enhance the lives of afflicted children.






Title : Long-read sequencing reveals dynamic features of human malignancies
Jianhua Luo, University of Pittsburgh School of Medicine, United States
Title : Nanomedicine in over 45,000 patients and no cancer
Thomas Jay Webster, Brown University, United States